Sign in
ADRX Stock Price, Chart, Stats & News
ADARx Pharmaceuticals, Inc.
Save
ADARx Pharmaceuticals, Inc. (ADRX) does not currently pay a dividend.
2.00B
Market cap
–
Current P/E
–
Forward P/E
ADRX chart
About
ADARx Pharmaceuticals, Inc. is a late-clinical-stage biotechnology company. It focuses on developing next-generation small interfering RNA (siRNA) therapeutics for diseases with significant unmet medical needs. The company was founded by Zhen Li in December 2019 and is headquartered in San Diego, CA.
Similar securities
Based on sector and market capitalization
Report issue